The technology provides rapid resistance profiling for recurrent or complicated infections and is approved for use in all 50 US states. Biotia has launched BIOTIA-DX Resistance, an antimicrobial resistance profiling technology now integrated into the company’s BIOTIA-ID Urine Test. The assay is approved under the New York State Clinical Laboratory Evaluation Program and is available for clinical use across all 50 US states, according to a press …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.